We are aware of current issues with the ONS login. Please clear your device history/cache/cookies before attempting to log in. Thank you for your patience as we address this issue.
To assess the benefit and harm of transarterial chemoembolization treatment when compared to no intervention or a placebo intervention for patients with liver metastases.
Members Only
Access to this article is restricted. Please log in to view the full article.
